Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.63 | 16.25 |
| PEG Ratio (TTM) | -5.96 | 1.70 |
| P/S Ratio (TTM) | 3.09 | 2.61 |
| P/B Ratio (TTM) | 0.96 | 1.90 |
| P/FCF Ratio (TTM) | 12.84 | 11.14 |
| Price to 5YR AVG Earnings Ratio | 33.81 | 14.10 |
| Price to 5YR AVG FCF Ratio | 11.28 | 8.07 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.81% | 1,502.82% |
| ROE (TTM) | 5.35% | 8.88% |
| Net Profit Margin (TTM) | 16.04% | 15.60% |
| ROIC 5YR AVG | 115.50% | 20.57% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.25% | 278.14% | 183.34% |
| Revenue | 9.76% | -4.02% | 12.09% |
| Net Income | 0.09% | 278.91% | 183.96% |
| Cash Flow | 118.95% | 499.52% | 288.38% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.33 | 3.19 |
| Quick Ratio (TTM) | 0.46 | 4.91 |
| D/E Ratio (TTM) | 0.00 | 1.27 |
| Interest Coverage (TTM) | 1.16 | 0.64 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | N/A | 0.38 |
| LTL to 5YR AVG FCF | N/A | 6.26 |
| Shares Outstanding Growth 5YR AVG | -0.60% | 4.88% |